Follow the people · Insider
Kerrii B. Anderson
Kerrii B. Anderson files insider transactions with the SEC as a director of Laboratory Corp Of America (LH). We hold 1 disclosed purchase or sale filed since 28 March 2006, 1 of them in the last 90 days.
- Files forLH
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
8 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 May 2006 — 17 August 2026Director · Laboratory Corp Of America (LH)122 Form 4 lines · source: SEC Form 4
- Filed 23 February 2018 — 3 August 2026Director · Abercrombie & Fitch Co /de/ (ANF)61 Form 4 lines · source: SEC Form 4
- Filed 17 April 2019 — 6 July 2026Director · Sherwin Williams Co (SHW)39 Form 4 lines · source: SEC Form 4
- Filed 30 September 2010 — 25 September 2025Director · Worthington Industries (WOR)77 Form 4 lines · source: SEC Form 4
- Filed 11 August 2009 — 6 January 2015Director · Chiquita Brands International (CQB)12 Form 4 lines · source: SEC Form 4
- Filed 26 October 2009 — 2 July 2012Director · P F Changs China Bistro (PFCB)12 Form 4 lines · source: SEC Form 4
- Filed 29 April 2002 — 29 September 2008CEO & President · Wendys International (WEN)40 Form 4 lines · source: SEC Form 4
- Filed 24 March 2006 — 29 September 2006Vice President · Tim Hortons (THI)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,000 shares of Labcorp HoldingsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- was granted 91 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 44 August 2026Phantom Stock · traded 3 August 2026 · filed 4 August 2026
- was granted 29 shares of Sherwin Williams CoSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- exercised options over 1,567 shares of Abercrombie & Fitch Co /de/SEC Form 45 June 2026Class A Common Stock · traded 3 June 2026 · filed 5 June 2026
- exercised options over 522 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 45 June 2026Phantom Stock · traded 3 June 2026 · filed 5 June 2026
- was granted 2,160 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 45 June 2026Restricted Stock Unit · traded 3 June 2026 · filed 5 June 2026
- exercised options over 2,089 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 45 June 2026Restricted Stock Unit · traded 3 June 2026 · filed 5 June 2026
- was granted 107 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 412 May 2026Phantom Stock · traded 4 May 2026 · filed 12 May 2026
- was granted 32 shares of Sherwin Williams CoSEC Form 48 April 2026Common Stock · traded 6 April 2026 · filed 8 April 2026
- was granted 558 shares of Sherwin Williams CoSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- was granted 558 shares of Sherwin Williams CoSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 897 shares of Labcorp HoldingsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- exercised options over 897 shares of Labcorp Holdings (a derivative holding)SEC Form 413 February 2026Restricted Stock Unit · traded 11 February 2026 · filed 13 February 2026
- exercised options over 897 shares of Labcorp Holdings (a derivative holding)SEC Form 413 February 2026Restricted Stock Unit · traded 11 February 2026 · filed 13 February 2026
- exercised options over 897 shares of Labcorp HoldingsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 773 shares of Labcorp Holdings (a derivative holding)SEC Form 412 February 2026Restricted Stock Unit · traded 10 February 2026 · filed 12 February 2026
- was granted 773 shares of Labcorp Holdings (a derivative holding)SEC Form 412 February 2026Restricted Stock Unit · traded 10 February 2026 · filed 12 February 2026
- was granted 93 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 44 February 2026Phantom Stock · traded 2 February 2026 · filed 4 February 2026
- was granted 93 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 44 February 2026Phantom Stock · traded 2 February 2026 · filed 4 February 2026
- was granted 29 shares of Sherwin Williams CoSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- was granted 29 shares of Sherwin Williams CoSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- was granted 125 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 44 November 2025Phantom Stock · traded 3 November 2025 · filed 4 November 2025
- was granted 29 shares of Sherwin Williams CoSEC Form 47 October 2025Common Stock · traded 3 October 2025 · filed 7 October 2025
- was granted 2,815 shares of Worthington EnterprisesSEC Form 426 September 2025Common Shares · traded 25 September 2025 · filed 26 September 2025
- was granted 286 shares of Worthington Enterprises (a derivative holding)SEC Form 424 September 2025Phantom Stock · traded 23 September 2025 · filed 24 September 2025
- ▼ sold on the open market 4,292 shares of Abercrombie & Fitch Co /de/SEC Form 43 September 2025Class A Common Stock · traded 29 August 2025 · filed 3 September 2025
- was granted 100 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 45 August 2025Phantom Stock · traded 4 August 2025 · filed 5 August 2025
- ▼ sold on the open market 3,500 shares of Labcorp HoldingsSEC Form 428 July 2025Common Stock · traded 24 July 2025 · filed 28 July 2025
- ▼ sold on the open market 3,500 shares of Labcorp HoldingsSEC Form 428 July 2025Common Stock · traded 24 July 2025 · filed 28 July 2025
- was granted 29 shares of Sherwin Williams CoSEC Form 49 July 2025Common Stock · traded 7 July 2025 · filed 9 July 2025
- ▼ sold on the open market 500 shares of Labcorp HoldingsSEC Form 42 July 2025Common Stock · traded 1 July 2025 · filed 2 July 2025
- was granted 2,089 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 413 June 2025Restricted Stock Unit · traded 11 June 2025 · filed 13 June 2025
- exercised options over 780 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 413 June 2025Restricted Stock Unit · traded 11 June 2025 · filed 13 June 2025
- exercised options over 780 shares of Abercrombie & Fitch Co /de/SEC Form 413 June 2025Class A Common Stock · traded 11 June 2025 · filed 13 June 2025
- ▼ sold on the open market 500 shares of Labcorp HoldingsSEC Form 412 June 2025Common Stock · traded 11 June 2025 · filed 12 June 2025
- was granted 128 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 47 May 2025Phantom Stock · traded 5 May 2025 · filed 7 May 2025
- was granted 30 shares of Sherwin Williams CoSEC Form 47 April 2025Common Stock · traded 4 April 2025 · filed 7 April 2025
- ▼ sold on the open market 500 shares of Labcorp HoldingsSEC Form 47 March 2025Common Stock · traded 5 March 2025 · filed 7 March 2025
- was granted 517 shares of Sherwin Williams CoSEC Form 420 February 2025Common Stock · traded 18 February 2025 · filed 20 February 2025
- was granted 897 shares of Labcorp Holdings (a derivative holding)SEC Form 413 February 2025Restricted Stock Unit · traded 11 February 2025 · filed 13 February 2025
- exercised options over 944 shares of Labcorp Holdings (a derivative holding)SEC Form 410 February 2025Restricted Stock Unit · traded 6 February 2025 · filed 10 February 2025
- exercised options over 944 shares of Labcorp HoldingsSEC Form 410 February 2025Common Stock · traded 6 February 2025 · filed 10 February 2025
- ▼ sold on the open market 1,000 shares of Labcorp HoldingsSEC Form 48 January 2025Common Stock · traded 7 January 2025 · filed 8 January 2025
- was granted 30 shares of Sherwin Williams CoSEC Form 47 January 2025Common Stock · traded 3 January 2025 · filed 7 January 2025
- gave away 2,000 shares of Abercrombie & Fitch Co /de/SEC Form 44 December 2024Class A Common Stock · traded 3 December 2024 · filed 4 December 2024
- ▼ sold on the open market 1,000 shares of Labcorp HoldingsSEC Form 425 October 2024Common Stock · traded 24 October 2024 · filed 25 October 2024
- was granted 27 shares of Sherwin Williams CoSEC Form 48 October 2024Common Stock · traded 4 October 2024 · filed 8 October 2024
- was granted 563 shares of Worthington Enterprises (a derivative holding)SEC Form 430 September 2024Phantom Stock · traded 27 September 2024 · filed 30 September 2024
- was granted 3,300 shares of Worthington EnterprisesSEC Form 427 September 2024Common Shares · traded 26 September 2024 · filed 27 September 2024
- ▼ sold on the open market 414 shares of Labcorp HoldingsSEC Form 49 August 2024Common Stock · traded 7 August 2024 · filed 9 August 2024
- ▼ sold on the open market 586 shares of Labcorp HoldingsSEC Form 49 August 2024Common Stock · traded 8 August 2024 · filed 9 August 2024
- was granted 34 shares of Sherwin Williams CoSEC Form 49 July 2024Common Stock · traded 5 July 2024 · filed 9 July 2024
- was granted 780 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 414 June 2024Restricted Stock Unit · traded 12 June 2024 · filed 14 June 2024
- exercised options over 4,292 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 412 June 2024Restricted Stock Unit · traded 10 June 2024 · filed 12 June 2024
- exercised options over 4,292 shares of Abercrombie & Fitch Co /de/SEC Form 412 June 2024Class A Common Stock · traded 10 June 2024 · filed 12 June 2024
- ▼ sold on the open market 900 shares of Abercrombie & Fitch Co /de/SEC Form 44 June 2024Class A Common Stock · traded 31 May 2024 · filed 4 June 2024
- ▼ sold on the open market 1,100 shares of Abercrombie & Fitch Co /de/SEC Form 44 June 2024Class A Common Stock · traded 31 May 2024 · filed 4 June 2024
- ▼ sold on the open market 2,100 shares of Abercrombie & Fitch Co /de/SEC Form 44 June 2024Class A Common Stock · traded 31 May 2024 · filed 4 June 2024
- ▼ sold on the open market 3,400 shares of Abercrombie & Fitch Co /de/SEC Form 44 June 2024Class A Common Stock · traded 31 May 2024 · filed 4 June 2024
- ▼ sold on the open market 250 shares of Laboratory Corp Of AmericaSEC Form 42 May 2024Common Stock · traded 30 April 2024 · filed 2 May 2024
- ▼ sold on the open market 250 shares of Laboratory Corp Of AmericaSEC Form 42 May 2024Common Stock · traded 2 May 2024 · filed 2 May 2024
- was granted 30 shares of Sherwin Williams CoSEC Form 49 April 2024Common Stock · traded 5 April 2024 · filed 9 April 2024
- ▼ sold on the open market 230 shares of Abercrombie & Fitch Co /de/SEC Form 411 March 2024Class A Common Stock · traded 8 March 2024 · filed 11 March 2024
- ▼ sold on the open market 2,770 shares of Abercrombie & Fitch Co /de/SEC Form 411 March 2024Class A Common Stock · traded 8 March 2024 · filed 11 March 2024
- was granted 594 shares of Sherwin Williams CoSEC Form 415 February 2024Common Stock · traded 13 February 2024 · filed 15 February 2024
- was granted 944 shares of Laboratory Corp Of America (a derivative holding)SEC Form 48 February 2024Restricted Stock Unit · traded 6 February 2024 · filed 8 February 2024
- exercised options over 947 shares of Laboratory Corp Of America (a derivative holding)SEC Form 48 February 2024Restricted Stock Unit · traded 7 February 2024 · filed 8 February 2024
- exercised options over 947 shares of Laboratory Corp Of AmericaSEC Form 48 February 2024Common Stock · traded 7 February 2024 · filed 8 February 2024
- was granted 34 shares of Sherwin Williams CoSEC Form 49 January 2024Common Stock · traded 5 January 2024 · filed 9 January 2024
- was granted 38 shares of Sherwin Williams CoSEC Form 410 October 2023Common Stock · traded 6 October 2023 · filed 10 October 2023
- was granted 2,300 shares of Worthington IndustriesSEC Form 42 October 2023Common Shares · traded 29 September 2023 · filed 2 October 2023
- ▼ sold on the open market 5,000 shares of Laboratory Corp Of AmericaSEC Form 410 August 2023Common Stock · traded 8 August 2023 · filed 10 August 2023
- ▼ sold on the open market 5,000 shares of Worthington IndustriesSEC Form 48 August 2023Common Shares · traded 7 August 2023 · filed 8 August 2023
- was granted 38 shares of Sherwin Williams CoSEC Form 410 July 2023Common Stock · traded 7 July 2023 · filed 10 July 2023
- was granted 4,292 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 412 June 2023Restricted Stock Unit · traded 8 June 2023 · filed 12 June 2023
- exercised options over 7,565 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 412 June 2023Restricted Stock Unit · traded 8 June 2023 · filed 12 June 2023
- exercised options over 7,565 shares of Abercrombie & Fitch Co /de/SEC Form 412 June 2023Class A Common Stock · traded 8 June 2023 · filed 12 June 2023
- was granted 43 shares of Sherwin Williams CoSEC Form 412 April 2023Common Stock · traded 10 April 2023 · filed 12 April 2023
- was granted 711 shares of Sherwin Williams CoSEC Form 416 February 2023Common Stock · traded 14 February 2023 · filed 16 February 2023
- exercised options over 742 shares of Laboratory Corp Of America (a derivative holding)SEC Form 414 February 2023Restricted Stock Unit · traded 11 February 2023 · filed 14 February 2023
- exercised options over 742 shares of Laboratory Corp Of AmericaSEC Form 414 February 2023Common Stock · traded 11 February 2023 · filed 14 February 2023
- was granted 849 shares of Laboratory Corp Of America (a derivative holding)SEC Form 49 February 2023Restricted Stock Unit · traded 7 February 2023 · filed 9 February 2023
- was granted 42 shares of Sherwin Williams CoSEC Form 410 January 2023Common Stock · traded 6 January 2023 · filed 10 January 2023
- was granted 46 shares of Sherwin Williams CoSEC Form 411 October 2022Common Stock · traded 7 October 2022 · filed 11 October 2022
- was granted 2,700 shares of Worthington IndustriesSEC Form 430 September 2022Common Shares · traded 28 September 2022 · filed 30 September 2022
- was granted 41 shares of Sherwin Williams CoSEC Form 412 July 2022Common Stock · traded 8 July 2022 · filed 12 July 2022
- exercised options over 904 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 410 June 2022Phantom Stock · traded 8 June 2022 · filed 10 June 2022
- was granted 7,565 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 410 June 2022Restricted Stock Unit · traded 8 June 2022 · filed 10 June 2022
- exercised options over 3,615 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 410 June 2022Restricted Stock Unit · traded 8 June 2022 · filed 10 June 2022
- exercised options over 2,711 shares of Abercrombie & Fitch Co /de/SEC Form 410 June 2022Class A Common Stock · traded 8 June 2022 · filed 10 June 2022
- was granted 37 shares of Sherwin Williams CoSEC Form 412 April 2022Common Stock · traded 8 April 2022 · filed 12 April 2022
- was granted 529 shares of Sherwin Williams CoSEC Form 417 February 2022Common Stock · traded 15 February 2022 · filed 17 February 2022
- was granted 742 shares of Laboratory Corp Of America (a derivative holding)SEC Form 415 February 2022Restricted Stock Unit · traded 11 February 2022 · filed 15 February 2022
- exercised options over 771 shares of Laboratory Corp Of America (a derivative holding)SEC Form 44 February 2022Restricted Stock Unit · traded 2 February 2022 · filed 4 February 2022
- gave away 345 shares of Laboratory Corp Of AmericaSEC Form 44 February 2022Common Stock · traded 14 December 2021 · filed 4 February 2022
- gave away 345 shares of Laboratory Corp Of AmericaSEC Form 44 February 2022Common Stock · traded 14 December 2021 · filed 4 February 2022
- gave away 860 shares of Laboratory Corp Of AmericaSEC Form 44 February 2022Common Stock · traded 14 December 2021 · filed 4 February 2022
- exercised options over 771 shares of Laboratory Corp Of AmericaSEC Form 44 February 2022Common Stock · traded 2 February 2022 · filed 4 February 2022
- was granted 202 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 42 February 2022Phantom Stock · traded 31 January 2022 · filed 2 February 2022
- was granted 30 shares of Sherwin Williams CoSEC Form 411 January 2022Common Stock · traded 7 January 2022 · filed 11 January 2022
- gave away 3,000 shares of Worthington IndustriesSEC Form 422 December 2021Common Shares · traded 20 December 2021 · filed 22 December 2021
- was granted 186 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 43 November 2021Phantom Stock · traded 1 November 2021 · filed 3 November 2021
- gave away 2,842 shares of Worthington IndustriesSEC Form 414 October 2021Common Shares · traded 3 September 2021 · filed 14 October 2021
- gave away 1,421 shares of Worthington IndustriesSEC Form 414 October 2021Common Shares · traded 3 September 2021 · filed 14 October 2021
- gave away 1,421 shares of Worthington IndustriesSEC Form 414 October 2021Common Shares · traded 3 September 2021 · filed 14 October 2021
- was granted 32 shares of Sherwin Williams CoSEC Form 413 October 2021Common Stock · traded 8 October 2021 · filed 13 October 2021
- was granted 439 shares of Worthington Industries (a derivative holding)SEC Form 44 October 2021Phantom Stock · traded 1 October 2021 · filed 4 October 2021
- was granted 2,400 shares of Worthington IndustriesSEC Form 430 September 2021Common Shares · traded 29 September 2021 · filed 30 September 2021
- ▲ bought on the open market 1,000 shares of Abercrombie & Fitch Co /de/SEC Form 42 September 2021Class A Common Stock · traded 2 September 2021 · filed 2 September 2021
- was granted 194 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 43 August 2021Phantom Stock · traded 2 August 2021 · filed 3 August 2021
- was granted 34 shares of Sherwin Williams CoSEC Form 47 July 2021Common Stock · traded 2 July 2021 · filed 7 July 2021
- exercised options over 13,205 shares of Abercrombie & Fitch Co /de/SEC Form 411 June 2021Class A Common Stock · traded 20 May 2021 · filed 11 June 2021
- exercised options over 13,205 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 411 June 2021Restricted Stock Unit · traded 20 May 2021 · filed 11 June 2021
- was granted 3,615 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 411 June 2021Restricted Stock Unit · traded 9 June 2021 · filed 11 June 2021
- was granted 195 shares of Abercrombie & Fitch Co /de/ (a derivative holding)SEC Form 45 May 2021Phantom Stock · traded 3 May 2021 · filed 5 May 2021
- was granted 35 shares of Sherwin Williams CoSEC Form 47 April 2021Common Stock · traded 5 April 2021 · filed 7 April 2021
- was granted 221 shares of Sherwin Williams CoSEC Form 418 February 2021Common Stock · traded 16 February 2021 · filed 18 February 2021
- exercised options over 986 shares of Laboratory Corp Of AmericaSEC Form 48 February 2021Common Stock · traded 4 February 2021 · filed 8 February 2021
- exercised options over 986 shares of Laboratory Corp Of America (a derivative holding)SEC Form 48 February 2021Restricted Stock Unit · traded 4 February 2021 · filed 8 February 2021
- gave away 746 shares of Laboratory Corp Of AmericaSEC Form 44 February 2021Common Stock · traded 3 December 2020 · filed 4 February 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.